NCT06876350 (Woodcast) is a NA clinical trial of Woodcasting Splint in Carpometacarpal (CMC) Joint Arthritis, sponsored by Foundation for Orthopaedic Research and Education.

Who is sponsoring NCT06876350?

NCT06876350 is sponsored by Foundation for Orthopaedic Research and Education.

What drugs are being tested in NCT06876350?

Interventions in NCT06876350: Woodcasting Splint, Control (Standard treatment).

What condition does NCT06876350 study?

NCT06876350 studies Carpometacarpal (CMC) Joint Arthritis.

Is NCT06876350 still recruiting?

NCT06876350 is currently recruiting now. Last updated 17 March 2025.

Last reviewed 2025-03-17 · How we verify

NCT06876350: Woodcast

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Woodcasting Versus Thermoplast Splint in CMC Arthroplasty

Recruiting now NA Last updated 17 March 2025

What this trial tests

NA trial testing Woodcasting Splint in Carpometacarpal (CMC) Joint Arthritis in 26 participants. Currently enrolling.

Timeline

3 October 2024

Primary endpoint
31 May 2025

30 June 2025

Quick facts

Lead sponsor	Foundation for Orthopaedic Research and Education
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	26
Start date	3 October 2024
Primary completion	31 May 2025
Estimated completion	30 June 2025
Sites	1 location across United States

Drugs / interventions tested

Woodcasting Splint
Control (Standard treatment) — full drug profile →

Conditions studied

Carpometacarpal (CMC) Joint Arthritis — all drugs for Carpometacarpal (CMC) Joint Arthritis →

Sponsor

Foundation for Orthopaedic Research and Education

Who can join

18 and older, any sex, with Carpometacarpal (CMC) Joint Arthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a prospective, randomized, nonblinded trial to evaluate patient preference in splints after having a carpometacarpal arthroplasty.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Evaluating Patient Compliance With Woodcast and Thermoplast Splints After Thumb Carpometacarpal Arthroplasty: A Randomized Controlled Trial.
Nguyen T, Hung VT, Hancock JU, Bailey D, et al · · 2026 · PMID 41656908 · DOI 10.1177/15589447251415394

Verify or expand the search:

Other Foundation for Orthopaedic Research and Education trials

Trials by the same sponsor.

NCT06663384 — ARVIS TKA vs Conventional TKA · NA · recruiting
NCT06350981 — Analgesic Requirement for Post-Operative Pain Control in TLIP Interbody Fusion · Phase 2, PHASE3 · enrolling by invitation
NCT06353893 — MRI Evaluation of Integrity Implant for Rotator Cuff Tears · active not recruiting
NCT05934500 — CBD Knee Scope Study · EARLY_PHASE1 · unknown
NCT05906433 — Optimal Anesthetic for Corticosteroid Injections for Knee Osteoarthritis · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06876350 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Foundation for Orthopaedic Research and Education
Last refreshed: 17 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06876350.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing